Balanced news tone
News Sentiment
BAJAJHCARE sentiment intelligence
Bajaj HealthCare Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
51
Balanced news tone
38 relevant articles
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
+1.2% over one week, +14.8% over four weeks, trend inactive, and near fair-value range.
Bajaj Healthcare hosts Q1FY27 earnings call on July 21
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
84/100 classification
One-week reaction
1.2%
Price digesting
Trend fit
Trend inactive
14.8% over four weeks
Fair value
-15.5%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
4
Neutral
31
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Business Standard
Direct company coverage
Bajaj Healthcare spikes 7% on posting healthy Q3 results; check details
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 19 Jan 2026 08:00
- Source
- Business Standard
CNBC TV18
Direct company coverage
Bajaj Healthcare Ltd. Share Price Today - Bajaj Healthcare Ltd. Stock Price Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jan 2026 07:56
- Source
- CNBC TV18
J.P. Morgan Private Bank
Direct company coverage
3 reasons we now favor the healthcare sector
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Dec 2025 08:00
- Source
- J.P. Morgan Private Bank
Equitypandit
Direct company coverage
Bajaj Healthcare Shares Rise 1.5% After CDSCO Clears Phase III Suvorexant Trials
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Oct 2025 07:00
- Source
- Equitypandit
CNBC TV18
Direct company coverage
Bajaj Healthcare gets CDSCO nod for phase III trials of suvorexant tablets for insomnia
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Oct 2025 07:00
- Source
- CNBC TV18
scanx.trade
Direct company coverage
Bajaj Healthcare Secures Approval for Phase III Trials of Insomnia Drug Suvorexant
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 04 Oct 2025 07:00
- Source
- scanx.trade
simplywall.st
Direct company coverage
Here's What We Like About Bajaj HealthCare's (NSE:BAJAJHCARE) Upcoming Dividend
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 15 Sep 2025 07:00
- Source
- simplywall.st
marketscreener.com
Direct company coverage
Bajaj Healthcare : Files Compulsory License With Indian Patent Office For Baricitinib
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Aug 2021 07:00
- Source
- marketscreener.com